DGAP-News: Epigenomics AG / Key word(s): Regulatory Admission/Miscellaneous 03.05.2019 / 10:09 The issuer is solely responsible for the content of this announcement. CMS accepts Epigenomics’ application for NCD review Berlin (Germany) and San Diego, CA (U.S.A.), May 2, 2019 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY; the “Company”) announces that the Centers for […]
Author: mark
02. April 2019
DGAP-DD: Epigenomics AG deutsch
Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen 02.04.2019 / 16:55 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 1. Angaben zu den Personen, die Führungsaufgaben wahrnehmen, sowie zu den in enger Beziehung zu ihnen stehenden Personen a) Name Name und […]
28. March 2019
Epigenomics (ECX-DE): 2018 results highlight strong underlying growth momentum
goetzpartners securities Limited 28-March-2019 / 19:54 GMT/BST Free to access research and investor meetings in a post-MiFID2 world. This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail […]
27. March 2019
Epigenomics AG Reports Results for Financial Year 2018
DGAP-News: Epigenomics AG / Key word(s): Annual Results 27.03.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Reports Results for Financial Year 2018 Berlin (Germany) und San Diego, CA (U.S.A.), March 27, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) today announced the financial results (according […]
15. March 2019
Correction of the Corporate News of March 15, 2019, 12:40 pm: Epigenomics AG: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 14:45 The issuer is solely responsible for the content of this announcement. Correction of the Corporate News of March 15, 2019, 12:40 pm: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying […]
15. March 2019
Epigenomics AG: U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 12:40 The issuer is solely responsible for the content of this announcement. Press release U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests Berlin (Germany) and San […]